In conclusion, the present study provides the evidence to support the preventive effect of Wnt/β-catenin activation on IR-related AKI and CKD, though more work is needed to elucidate the exact mechanisms by which exogenous Wnt1 protects against AKI and CKD. This evidence concerns the gene WNT1 and chronic kidney disease.